These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17696813)

  • 21. Bone morphogenetic protein-7 release from endogenous neural precursor cells suppresses the tumourigenicity of stem-like glioblastoma cells.
    Chirasani SR; Sternjak A; Wend P; Momma S; Campos B; Herrmann IM; Graf D; Mitsiadis T; Herold-Mende C; Besser D; Synowitz M; Kettenmann H; Glass R
    Brain; 2010 Jul; 133(Pt 7):1961-72. PubMed ID: 20513660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stem cells in cancer: instigators and propagators?
    Alison MR; Islam S; Wright NA
    J Cell Sci; 2010 Jul; 123(Pt 14):2357-68. PubMed ID: 20592182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
    Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
    BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Barrett's oesophageal adenocarcinoma encompasses tumour-initiating cells that do not express common cancer stem cell markers.
    Grotenhuis BA; Dinjens WN; Wijnhoven BP; Sonneveld P; Sacchetti A; Franken PF; van Dekken H; Tilanus HW; van Lanschot JJ; Fodde R
    J Pathol; 2010 Aug; 221(4):379-89. PubMed ID: 20549647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer stem cell: fundamental experimental pathological concepts and updates.
    Islam F; Qiao B; Smith RA; Gopalan V; Lam AK
    Exp Mol Pathol; 2015 Apr; 98(2):184-91. PubMed ID: 25659759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine.
    Kim SS; Harford JB; Pirollo KF; Chang EH
    Biochem Biophys Res Commun; 2015 Dec; 468(3):485-9. PubMed ID: 26116770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of brain tumour initiating cells using the stem cell marker aldehyde dehydrogenase.
    Choi SA; Lee JY; Phi JH; Wang KC; Park CK; Park SH; Kim SK
    Eur J Cancer; 2014 Jan; 50(1):137-49. PubMed ID: 24103144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesenchymal differentiation of glioblastoma stem cells.
    Ricci-Vitiani L; Pallini R; Larocca LM; Lombardi DG; Signore M; Pierconti F; Petrucci G; Montano N; Maira G; De Maria R
    Cell Death Differ; 2008 Sep; 15(9):1491-8. PubMed ID: 18497759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro generation of human cells with cancer stem cell properties.
    Scaffidi P; Misteli T
    Nat Cell Biol; 2011 Aug; 13(9):1051-61. PubMed ID: 21857669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer stem cells in nervous system tumors.
    Singh SK; Clarke ID; Hide T; Dirks PB
    Oncogene; 2004 Sep; 23(43):7267-73. PubMed ID: 15378086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Personalized regulation of glioblastoma cancer stem cells based on biomedical technologies: From theory to experiment (Review).
    Bryukhovetskiy I; Ponomarenko A; Lyakhova I; Zaitsev S; Zayats Y; Korneyko M; Eliseikina M; Mischenko P; Shevchenko V; Shanker Sharma H; Sharma A; Khotimchenko Y
    Int J Mol Med; 2018 Aug; 42(2):691-702. PubMed ID: 29749540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer stem cells--the current status of an old concept: literature review and clinical approaches.
    Fulawka L; Donizy P; Halon A
    Biol Res; 2014 Dec; 47(1):66. PubMed ID: 25723910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The new challenge of stem cell: brain tumour therapy.
    Colleoni F; Torrente Y
    Cancer Lett; 2008 Dec; 272(1):1-11. PubMed ID: 18621474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunology of cancer stem cells in solid tumours. A review.
    Maccalli C; Volontè A; Cimminiello C; Parmiani G
    Eur J Cancer; 2014 Feb; 50(3):649-55. PubMed ID: 24333096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting cancer stem-like cells in glioblastoma and colorectal cancer through metabolic pathways.
    Kahlert UD; Mooney SM; Natsumeda M; Steiger HJ; Maciaczyk J
    Int J Cancer; 2017 Jan; 140(1):10-22. PubMed ID: 27389307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of A1 and A2B adenosine receptor activity: a new strategy to sensitise glioblastoma stem cells to chemotherapy.
    Daniele S; Zappelli E; Natali L; Martini C; Trincavelli ML
    Cell Death Dis; 2014 Nov; 5(11):e1539. PubMed ID: 25429616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling.
    Malanchi I; Peinado H; Kassen D; Hussenet T; Metzger D; Chambon P; Huber M; Hohl D; Cano A; Birchmeier W; Huelsken J
    Nature; 2008 Apr; 452(7187):650-3. PubMed ID: 18385740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The developing cancer stem-cell model: clinical challenges and opportunities.
    Vermeulen L; de Sousa e Melo F; Richel DJ; Medema JP
    Lancet Oncol; 2012 Feb; 13(2):e83-9. PubMed ID: 22300863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer stem cells: problems for therapy?
    Alison MR; Lim SM; Nicholson LJ
    J Pathol; 2011 Jan; 223(2):147-61. PubMed ID: 21125672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineering cancer stem-like cells from normal human lung epithelial cells.
    Sasai K; Takao-Rikitsu E; Sukezane T; Yanagita E; Nakagawa H; Itoh-Yagi M; Izumi Y; Itoh T; Akagi T
    PLoS One; 2017; 12(4):e0175147. PubMed ID: 28380052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.